Zoetis ROE Ratio 2011-2026 | ZTS

Annual ROE Ratio Zoetis

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
80.25	52.12	46.96	48.01	44.83	43.41	55.39	65.35	48.38	54.77	31.07	43.61	52.39	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
80.25	31.07	51.27

Quarterly ROE Ratio Zoetis

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
54.37	54.04	52.2	37.47	49.21	47.93	49.87	38.56	49.91	49.51	46.54	35.67	47.46	47.91	48.13	37.23	49.94	50.86	49.09	33.93	48.11	51.4	55.09	55.39	57.0	57.39	63.19	69.62	58.41	58.86	53.33	48.81	54.59	53.83	54.94	55.21	46.92	48.54	30.01	31.74	39.29	34.26	48.1	44.47	46.03	47.3	50.55	53.62	42.2	32.29	22.97	10.83	11.08	7.05	2.76	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
69.62	2.76	45.0

ROE Ratio of other stocks in the Biotechnology industry

Issuer	ROE Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	15.76	-	2.43 %	$ 254 M	Germany
I-Mab IMAB	-85.31	-	-	$ 866 M	China
Midatech Pharma plc MTP	-330.29	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	5.18	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	-5.9	$ 0.89	1.48 %	$ 6.54 M	China
Biophytis SA BPTS	-751.94	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	626.29	-	2.54 %	$ 160 B	France
Evogene Ltd. EVGN	-41.09	$ 0.75	-4.66 %	$ 27.9 M	Israel
ACADIA Pharmaceuticals ACAD	30.9	$ 22.2	-2.07 %	$ 3.68 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	-115.61	-	-1.52 %	$ 24.7 M	USA
Applied Molecular Transport AMTI	-207.64	-	-	$ 10.1 M	USA
Galapagos NV GLPG	-11.44	$ 27.86	-1.97 %	$ 2.69 B	Belgium
Advaxis ADXS	196.88	-	-9.65 %	$ 45.9 M	USA
Innate Pharma S.A. IPHA	-41.02	$ 1.49	6.43 %	$ 235 M	France
Институт стволовых клеток человека ISKJ	17.55	-	-	-	Russia
Aeterna Zentaris AEZS	-401.79	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	51843.24	-	-10.17 %	$ 12.2 K	USA
BioNTech SE BNTX	1.11	$ 101.57	-0.48 %	$ 27.2 B	Germany
Brainstorm Cell Therapeutics BCLI	103.22	-	-2.5 %	$ 5.88 M	USA
Aeglea BioTherapeutics AGLE	-21.7	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-62.37	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-32.34	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	-33.6	-	-	$ 3.67 B	USA
Akouos AKUS	-37.09	-	0.23 %	$ 488 M	USA
Allakos ALLK	-110.0	-	-	$ 28.6 M	USA
AlloVir ALVR	-55.11	-	4.14 %	$ 49.1 M	USA
Can-Fite BioPharma Ltd. CANF	-175.75	$ 2.98	2.41 %	$ 4.91 M	Israel
Ampio Pharmaceuticals AMPE	-256.9	-	-11.43 %	$ 502 K	USA
CureVac N.V. CVAC	-59.8	-	-	$ 867 M	Germany
Applied Therapeutics APLT	698.49	-	-	$ 8.42 M	USA
Aptose Biosciences APTO	93.75	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-169.38	-	-39.0 %	$ 4.57 M	USA
Aquestive Therapeutics AQST	248.9	$ 4.05	-0.98 %	$ 433 M	USA
Aravive ARAV	-716.17	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	125.33	-	17.91 %	$ 11.1 M	USA
Arcutis Biotherapeutics ARQT	-8.52	$ 22.37	-3.95 %	$ 2.85 B	USA
Allena Pharmaceuticals ALNA	-257.91	-	3.16 %	$ 1.9 M	USA
Nanobiotix S.A. NBTX	-47.67	$ 32.99	-0.39 %	$ 286 B	France
Athira Pharma ATHA	-380.03	-	-	$ 269 M	USA
Alpine Immune Sciences ALPN	-32.19	-	-	$ 2.17 B	USA
Avenue Therapeutics ATXI	-158.79	-	-52.27 %	$ 4.45 M	USA
Aileron Therapeutics ALRN	-294.78	-	10.36 %	$ 9.8 M	USA
Autolus Therapeutics plc AUTL	-161.42	$ 1.41	-4.73 %	$ 375 M	Britain
AVROBIO AVRO	12.83	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	3458.87	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	20.44	-	-	$ 96.9 B	Britain
Atreca BCEL	-123.92	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	45.18	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	6.58	-	0.49 %	$ 251 B	Cayman-islands